Weight-based Dosing for Dense Weekly Paclitaxel and Carboplatin in Overweight Patients w/ Body Surface Area (BSA) > 2.0

Summary

The purpose of this study is to evaluate the side effects and effectiveness of giving standard paclitaxel chemotherapy in doses based on actual body surface area in combination with standard dosed carboplatin chemotherapy for overweight women.

Timeline

Start

2016-04-20

Primary completion

2018-08-16

Completion

2019-01-24

Outcome

Outcome not reported

Stopped (Enrollment): “Lack of accrual - terminated”

Drugs

Indications